Cepheid, Gen-Probe, Xceed Molecular, USDA, NIH-GenBank, DNAVision, Ipsogen, Wellcome Trust, Takeda, Novartis, Daiichi Sankyo, SAE Consortium | GenomeWeb
Cepheid Gets OK to Market Molecular Dxs in Canada, Mexico
Cepheid said this week that regulatory authorities in Canada and Mexico have cleared for marketing certain of the firm’s molecular diagnostic tests for hospital-acquired infections.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.